Pregabalin Capsule
Product Images NDC 71205-875

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71205-875). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pregabalin 01)

FDA Label Image

Figure 1 (Pregabalin 02)

FDA Label Image

Figure 2 (Pregabalin 03)

This is a report on the percentage of improvement of pain from the baseline for patients taking Pregabai 100 mg per day. The values indicate the time of day and the percentage of improvement in pain from baseline at that time. However, the text is not very clear and may contain errors in recognition.*

FDA Label Image

Figure 3 (Pregabalin 04)

This is a chart showing the percentage of patients who experienced improvement in pain when taking Pregabalin at different doses versus those taking a placebo. A range from 0 to 100 percent improvement is presented. There is no additional information available.*

FDA Label Image

Figure 4 (Pregabalin 05)

This appears to be a chart or graph displaying the percentage of patients who experienced improvement in pain based on the dosage of Pregabalin (200mg three times a day vs 100mg three times a day) compared to a placebo. The chart shows the percentage of improvement in pain from a baseline level, with values ranging from 0 to 270.*

FDA Label Image

Figure 5 (Pregabalin 06)

FDA Label Image

Figure 6 (Pregabalin 07)

FDA Label Image

Figure 7 (Pregabalin 08)

This appears to be a graph or chart showing the median percentage change from baseline for seizure reduction in several studies labeled as E1 BID, E2TID, E3 BID, and E3 TID. The x-axis appears to show different dosage levels in mg/day, with the title "Dose = Pacabo" at 0 mg/day. However, the text is not clear enough to provide a more detailed or accurate description.*

FDA Label Image

Figure 9 (Pregabalin 09)

FDA Label Image

Figure 10 (Pregabalin 10)

FDA Label Image

Figure 11 (Pregabalin 11)

FDA Label Image

Figure 12 (Pregabalin 12)

FDA Label Image

71205-869-30 (Pregabalin 13)

This appears to be the text from a prescription medication label. The medication is Pregabalin in a 25mg strength, with 30 capsules in the container. It is important for each patient to use the accompanying medication guide. The product ID is QP0BE930. The rest of the text is either gibberish or not-available.*

FDA Label Image

71205-870-30 (Pregabalin 14)

This is a prescription of Pregabalin in capsule form, with each capsule containing 50 mg of the drug. The prescription has a quantity of 60 capsules and is only available with a prescription. The NDC (National Drug Code) number for this product is 71205-870-60, and the product ID is QP0B7060. The weight of the prescription is 1o e poc 20, and it comes with a Medication Guide for the patient.*

FDA Label Image

71205-871-30 (Pregabalin 15)

This is a prescription information label for Pregabalin 75mg C-V capsules. The label has information about the product ID, quantity (30), the name of the manufacturer (S Pramacden), and the address of the manufacturer. There is also a warning to keep the medication out of reach of children.*

FDA Label Image

71205-872-30 (Pregabalin 16)

This document is a prescription label for Pregabalin capsules. Each capsule contains 100mg of Pregabalin. It advises to dispense the accompanying medication guide to each patient. The document also provides dosage and usage instructions. There is a product ID and prescription information given along with a manufacturer name. The label instructs to keep the medication out of each child's reach.*

FDA Label Image

71205-873-30 (Pregabalin 17)

This is a medication label for Pregabalin 150mg, containing 30 capsules. The label includes dosage instructions and a product ID. The medication is available by prescription only and should be kept out of reach of children.*

FDA Label Image

71205-874-30 (Pregabalin 18)

This is a description for a prescription drug called Pregabalin, which comes in the form of 30 capsules, each containing 200mg. It is categorized as a C-V drug and is only available through prescription (RX only). The product ID is QP087430, and it is manufactured by a company called Giapros. The label also includes instructions to keep it out of reach of children. No other information is available.*

FDA Label Image

71205-875-30 (Pregabalin 19)

This is a description of a medication called Pregabalin. Each capsule contains 225mg of pregabalin, and it is only available with a prescription (RX only). Pregabalin is a controlled substance and is listed under Schedule V. The medication comes in a capsule form and must be diagnosed by a medical professional. The text also includes a product code, which is QP087530. However, there is also some unclear and unrelated text that cannot be interpreted.*

FDA Label Image

71205-876-30 (Pregabalin 20)

This is a medication description for Pregabalin 300mg in the form of #60 capsules. The text includes the standard prescription information, a list of ingredients, and product identification numbers. There may be some errors present in the text, and no other useful information is available.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.